Markets:

Overview

News

Currencies

International

Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.3706 +0.0221 (+6.34%)

Streaming Delayed Price Updated: 10:08 AM EDT, Aug 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Ensysce Biosciences Announces Completion of Clinical Portion of Human Abuse Potential Trial PF614-103

August 23, 2022

Via ACCESSWIRE

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call

August 17, 2022

Via ACCESSWIRE

Ensysce Biosciences Provides Business Update and Reports Second Quarter 2022 Financial Results

August 11, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 18, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket ↗

August 11, 2022

Gainers

Via Benzinga

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗

August 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.

Via Benzinga

Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session ↗

August 11, 2022

Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 11, 2022

Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 09, 2022

Via Benzinga

Ensysce Biosciences Announces Completion of $8 Million Convertible Note Financing

August 09, 2022

Via ACCESSWIRE

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 27, 2022

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 05, 2022

On Friday, 72 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 27, 2022

Gainers

Via Benzinga

Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call

July 27, 2022

Via ACCESSWIRE

Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call

July 27, 2022

~ BE Study of PF614 Represents Critical Progress Toward FDA Approval ~~ Supports the 505(b)(2) Regulatory Path for Clinical Development of PF614 ~SAN DIEGO, CA / ACCESSWIRE / July 27, 2022 / Ensysce...

From Ensysce Biosciences, Inc.

Via AccessWire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 15, 2022

Gainers

Via Benzinga

Ensysce Biosciences Announces Initial Patients Dosed of First Human Abuse Potential Study

July 13, 2022

~ Trial Designed to Test and Confirm Nasal Opioid Manipulation ~

From Ensysce Biosciences, Inc.

Via AccessWire

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today? ↗

July 01, 2022

Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat.

Via InvestorPlace

Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today? ↗

July 01, 2022

Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.

Via InvestorPlace

Ensysce Biosciences Secures $8 Million Convertible Note Financing

July 01, 2022

~ Additional Funding from Investor Cohort Validates Company's Mission ~

From Ensysce Biosciences, Inc.

Via AccessWire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 01, 2022

Via Benzinga

Akebia Therapeutics And 20 Stocks Moving Premarket ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform

June 27, 2022

SAN DIEGO, CA / ACCESSWIRE / June 27, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC) (OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to...

From Ensysce Biosciences, Inc.

Via AccessWire

Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting

June 21, 2022

- Shareholder Meeting to be Held on Thursday, June 23rd at 9:00 AM PT

From Ensysce Biosciences, Inc.

Via AccessWire

Topics Death Intellectual Property

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.